$0.20+0.01 (+5.08%)
News25/Ratings0
Latest news
25 items- SECSEC Form 424B3 filed by Carmell Corporation424B3 - Longevity Health Holdings, Inc. (0001842939) (Filer)
- SECCarmell Corporation filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders8-K - Longevity Health Holdings, Inc. (0001842939) (Filer)
- SECSEC Form 424B3 filed by Carmell Corporation424B3 - Longevity Health Holdings, Inc. (0001842939) (Filer)
- SECCarmell Corporation filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits8-K - Longevity Health Holdings, Inc. (0001842939) (Filer)
- PRCARMELL CORP REBRANDS AS LONGEVITY HEALTH HOLDINGS TO HIGHLIGHT BUSINESS FOCUS & GROWTH STRATEGYPittsburgh, PA, March 10, 2025 (GLOBE NEWSWIRE) -- PITTSBURGH, Mar. 10, 2025 (GLOBE NEWSWIRE) -- Carmell Corporation (NASDAQ:CTCX, CTCXW)), a bio-aesthetics company (the "Company", "we", "our", or "us"), today announced a comprehensive corporate rebranding initiative aimed at better aligning the Company's market and investor facing image with its business focus and growth strategy. As part of the rebranding, the Company has changed its corporate name to "Longevity Health Holdings, Inc." and, at the open of trading on March 10, 2025, the Company's common stock and redeemable warrants will begin trading under the symbols "XAGE" and "XAGEW", respectively. The Company has also launc
- SECSEC Form 424B3 filed by Carmell Corporation424B3 - Longevity Health Holdings, Inc. (0001842939) (Filer)
- SECCarmell Corporation filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing8-K - Longevity Health Holdings, Inc. (0001842939) (Filer)
- SECSEC Form 424B3 filed by Carmell Corporation424B3 - Carmell Corp (0001842939) (Filer)
- SECSEC Form EFFECT filed by Carmell CorporationEFFECT - Carmell Corp (0001842939) (Filer)
- SECSEC Form DEF 14A filed by Carmell CorporationDEF 14A - Carmell Corp (0001842939) (Filer)
- SECSEC Form DEF 14A filed by Carmell CorporationDEF 14A - Carmell Corp (0001842939) (Filer)
- SECSEC Form S-3 filed by Carmell CorporationS-3 - Carmell Corp (0001842939) (Filer)
- SECSEC Form PRE 14A filed by Carmell CorporationPRE 14A - Carmell Corp (0001842939) (Filer)
- SECSEC Form D filed by Carmell CorporationD - Carmell Corp (0001842939) (Filer)
- SECSEC Form 424B3 filed by Carmell Corporation424B3 - Carmell Corp (0001842939) (Filer)
- SECCarmell Corporation filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits8-K - Carmell Corp (0001842939) (Filer)
- SECSEC Form 424B3 filed by Carmell Corporation424B3 - Carmell Corp (0001842939) (Filer)
- SECCarmell Corporation filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Unregistered Sales of Equity Securities, Other Events, Financial Statements and Exhibits8-K - Carmell Corp (0001842939) (Filer)
- PRCarmell Announces Closing of Elevai Skincare AcquisitionPITTSBURGH, Jan. 16, 2025 (GLOBE NEWSWIRE) -- Carmell Corporation (NASDAQ:CTCX), a bio-aesthetics company focused on skin and hair health ("Carmell", the "Company", "we", "our", or "us"), today announced the closing of the previously announced acquisition of the skin and hair care business of Elevai Skincare, Inc. ("Elevai"), a leader in physician dispensed exosome skin and hair care products, pursuant to a definitive purchase agreement with PMGC Holdings Inc. (formerly Elevai Labs Inc.) ("PMGC") and Elevai, its wholly owned subsidiary (the "Acquisition"). At the closing of the Acquisition (the "Closing"), the purchase consideration consisted of the following: Approximately $1.1 mill
- SECSEC Form D filed by Carmell CorporationD - Carmell Corp (0001842939) (Filer)
- SECSEC Form 424B3 filed by Carmell Corporation424B3 - Carmell Corp (0001842939) (Filer)
- SECCarmell Corporation filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements and Exhibits8-K - Carmell Corp (0001842939) (Filer)
- PRCarmell Announces Closing of Previously Announced PIPE Investment from Existing and New Investors to Support Commercial Build-outPITTSBURGH, Jan. 03, 2025 (GLOBE NEWSWIRE) -- Carmell Corporation (NASDAQ:CTCX), a bio-aesthetics company focused on skin and hair health ("Carmell", the "Company", "we", "our", or "us"), today announced the closing of its previously announced private placement with new and existing investors pursuant to a securities purchase agreement, dated December 23, 2024, for the issuance and sale of 8,065,210 shares of its common stock and an equal number of five-year warrants both priced at $0.23 per share, in a private placement for aggregate gross proceeds of $1.85 million before deducting offering expenses and fees (the "Private Placement"). The Private Placement was priced at a slight premium t
- PRCarmell Announces Execution of Definitive Agreement to Acquire Elevai Skincare, a leader in Physician Dispensed Exosome Skin and Hair Care ProductsPITTSBURGH, Jan. 02, 2025 (GLOBE NEWSWIRE) -- Carmell Corporation (NASDAQ:CTCX), a bio-aesthetics company focused on skin and hair health ("Carmell", the "Company", "we", "our", or "us"), today announced that it entered into a definitive purchase agreement with PMGC Holdings Inc. (formerly Elevai Labs Inc.) and its wholly owned subsidiary, Elevai Skincare Inc. ("Elevai"), to acquire the assets related to its skincare and haircare business (the "Acquisition"). The purchase consideration for the Acquisition is as follows: Approximately $1.1 million in Carmell common stock at the closing of the Acquisition (the "Closing");Approximately $57,000 in cash upon the sale of specified inventory ex
- SECSEC Form 424B3 filed by Carmell Corporation424B3 - Carmell Corp (0001842939) (Filer)